Vascular mechanisms of testosterone: The non-genomic point of view

Kaushik, 2010, Cardiovascular disease and androgens: a review, Int. J. Cardiol., 142, 8, 10.1016/j.ijcard.2009.10.033 Michels, 2006, Long-term and immediate effect of testosterone on single T-type calcium channel in neonatal rat cardiomyocytes, Endocrinology, 147, 5160, 10.1210/en.2006-0186 Jones, 2018, Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system, Asian J. Androl., 20, 120, 10.4103/aja.aja_6_18 Goldstajn, 2016, Sex hormone binding globulin (SHBG) as a marker of clinical disorders, Coll. Antropol., 40, 211 Elagizi, 2018, Testosterone and cardiovascular health, Mayo Clin. Proc., 93, 83, 10.1016/j.mayocp.2017.11.006 Oskui, 2013, Testosterone and the cardiovascular system: a comprehensive review of the clinical literature, J. Am. Heart Assoc., 2, 10.1161/JAHA.113.000272 Yeap, 2018, Testosterone treatment in older men: clinical implications and unresolved questions from the Testosterone Trials, Lancet Diabetes Endocrinol., 6, 659, 10.1016/S2213-8587(17)30416-3 Feldman, 2002, Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study, J. Clin. Endocrinol. Metab., 87, 589, 10.1210/jcem.87.2.8201 Yeap, 2014, Sex steroids and cardiovascular disease, Asian J. Androl., 16, 239, 10.4103/1008-682X.122357 Chrysant, 2018, Controversies regarding the cardiovascular effects of testosterone replacement therapy in older men, Drugs Today, 54, 25, 10.1358/dot.2018.54.1.2737935 Gagliano-Juca, 2019, Testosterone replacement therapy and cardiovascular risk, Nat. Revi. Cardiol., 16, 555, 10.1038/s41569-019-0211-4 Tambo, 2016, Testosterone and cardiovascular disease, Open Cardiovasc. Med. J., 10, 1, 10.2174/1874192401610010001 Khaw, 2007, Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study, Circulation, 116, 2694, 10.1161/CIRCULATIONAHA.107.719005 Traish, 2011, Testosterone and cardiovascular disease: an old idea with modern clinical implications, Atherosclerosis, 214, 244, 10.1016/j.atherosclerosis.2010.08.078 Ruehlmann, 2000, Rapid non-genomic vasodilator actions of oestrogens and sex steroids, Curr. Med. Chem., 7, 533, 10.2174/0929867003375038 Longcope, 1969, Conversion of blood androgens to estrogens in normal adult men and women, J. Clin. Invest., 48, 2191, 10.1172/JCI106185 Luu-The, 2008, Androgen biosynthetic pathways in the human prostate, Best Pract. Res. Clin. Endocrinol. Metab., 22, 207, 10.1016/j.beem.2008.01.008 Walters, 2008, Androgen actions and the ovary, Biol. Reprod., 78, 380, 10.1095/biolreprod.107.064089 Rainey, 2008, Regulation of the adrenal androgen biosynthesis, J. Steroid Biochem. Mol. Biol., 108, 281, 10.1016/j.jsbmb.2007.09.015 Mendis-Handagama, 2005, Leydig cells, thyroid hormones and steroidogenesis, Indian J. Exp. Biol., 43, 939 Miller, 2002, Androgen biosynthesis from cholesterol to DHEA, Mol. Cell. Endocrinol., 198, 7, 10.1016/S0303-7207(02)00363-5 Franchimont, 1983, Regulation of gonadal androgen secretion, Horm. Res., 18, 7, 10.1159/000179774 Rege, 2013, Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation, J. Clin. Endocrinol. Metab., 98, 1182, 10.1210/jc.2012-2912 du Toit, 2017, Profiling adrenal 11beta-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC(2)-MS/MS quantification of 11beta-hydroxytestosterone, 11keto-testosterone and 11keto-dihydrotestosterone, J. Steroid Biochem. Mol. Biol., 166, 54, 10.1016/j.jsbmb.2016.06.009 Barnard, 2017, Adrenal C11-oxy C21 steroids contribute to the C11-oxy C19 steroid pool via the backdoor pathway in the biosynthesis and metabolism of 21-deoxycortisol and 21-deoxycortisone, J. Steroid Biochem. Mol. Biol., 174, 86, 10.1016/j.jsbmb.2017.07.034 du Toit, 2018, Inefficient UGT-conjugation of adrenal 11beta-hydroxyandrostenedione metabolites highlights C11-oxy C19 steroids as the predominant androgens in prostate cancer, Mol. Cell. Endocrinol., 461, 265, 10.1016/j.mce.2017.09.026 van Rooyen, 2018, The in vitro metabolism of 11beta-hydroxyprogesterone and 11-ketoprogesterone to 11-ketodihydrotestosterone in the backdoor pathway, J. Steroid Biochem. Mol. Biol., 178, 203, 10.1016/j.jsbmb.2017.12.014 du Toit, 2018, A high-throughput UPC(2)-MS/MS method for the separation and quantification of C19 and C21 steroids and their C11-oxy steroid metabolites in the classical, alternative, backdoor and 11OHA4 steroid pathways, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 1080, 71, 10.1016/j.jchromb.2018.02.023 du Toit, 2018, C11-oxy C19 and C11-oxy C21 steroids in neonates: UPC(2)-MS/MS quantification of plasma 11beta-hydroxyandrostenedione, 11-ketotestosterone and 11-ketoprogesterone, Steroids, 138, 1, 10.1016/j.steroids.2018.06.003 Hakim, 2017, Gestational hyperandrogenism in developmental programming, Endocrinology, 158, 199, 10.1210/en.2016-1801 Pasqualini, 2005, Enzymes involved in the formation and transformation of steroid hormones in the fetal and placental compartments, J. Steroid Biochem. Mol. Biol., 97, 401, 10.1016/j.jsbmb.2005.08.004 Carr, 1981, De novo synthesis of cholesterol by the human fetal adrenal gland, Endocrinology, 108, 2154, 10.1210/endo-108-6-2154 Iyer, 2016, Androgens, Front. Horm. Res., 47, 82, 10.1159/000445159 Evans, 1988, The steroid and thyroid hormone receptor superfamily, Science, 240, 889, 10.1126/science.3283939 Foradori, 2008, Non-genomic actions of androgens, Front. Neuroendocrinol., 29, 169, 10.1016/j.yfrne.2007.10.005 Lucas-Herald, 2017, Genomic and non-genomic effects of androgens in the cardiovascular system: clinical implications, Clin. Sci., 131, 1405, 10.1042/CS20170090 Heinlein, 2002, The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions, Mol. Endocrinol., 16, 2181, 10.1210/me.2002-0070 Michels, 2008, Rapid actions of androgens, Front. Neuroendocrinol., 29, 182, 10.1016/j.yfrne.2007.08.004 Wehling, 1997, Specific, nongenomic actions of steroid hormones, Annu. Rev. Physiol., 59, 365, 10.1146/annurev.physiol.59.1.365 Khalil, 2005, Sex hormones as potential modulators of vascular function in hypertension, Hypertension, 46, 249, 10.1161/01.HYP.0000172945.06681.a4 Losel, 2003, Nongenomic actions of steroid hormones, Nat. Rev. Mol. Cell Biol., 4, 46, 10.1038/nrm1009 Szego, 1967, Adenosine 3′,5′-monophosphate in rat uterus: acute elevation by estrogen, Proc. Natl. Acad. Sci. U. S. A., 58, 1711, 10.1073/pnas.58.4.1711 Saldanha, 2013, Long- and short-term effects of androgens in human umbilical artery smooth muscle, Clin. Exp. Pharmacol. Physiol., 40, 181, 10.1111/1440-1681.12047 Yildiz, 2007, Vasodilating mechanisms of testosterone, Exp. Clin. Endocrinol. Diabetes, 115, 1, 10.1055/s-2007-949657 Jones, 2003, The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action?, Br. J. Pharmacol., 138, 733, 10.1038/sj.bjp.0705141 Thomas, 2019, Membrane androgen receptors unrelated to nuclear steroid receptors, Endocrinology, 160, 772, 10.1210/en.2018-00987 Salom, 2002, Acute relaxant effects of 17-beta-Estradiol through non-genomic mechanisms in rabbit carotid artery, Steroids, 67, 339, 10.1016/S0039-128X(01)00185-4 English, 2001, Gender differences in the vasomotor effects of different steroid hormones in rat pulmonary and coronary arteries, Horm. Metab. Res., 33, 645, 10.1055/s-2001-18689 Fausett, 1999, The effects of sex steroids on human umbilical artery and vein, J. Soc. Gynecol. Investig., 6, 27, 10.1016/S1071-5576(98)00040-9 Feldman, 2010, Rapid vascular effects of steroids - a question of balance?, Can. J. Cardiol., 26, 22A, 10.1016/S0828-282X(10)71057-6 Hu, 2012, Function and regulation of large conductance Ca(2+)-activated K+ channel in vascular smooth muscle cells, Drug Discov. Today, 17, 974, 10.1016/j.drudis.2012.04.002 Yue, 1995, Testosterone relaxes rabbit coronary arteries and aorta, Circulation, 91, 1154, 10.1161/01.CIR.91.4.1154 Tep-areenan, 2002, Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels, Br. J. Pharmacol., 135, 735, 10.1038/sj.bjp.0704522 Chou, 1996, Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo, Circulation, 94, 2614, 10.1161/01.CIR.94.10.2614 Yildiz, 2005, Testosterone relaxes human internal mammary artery in vitro, J. Cardiovasc. Pharmacol., 45, 580, 10.1097/01.fjc.0000161400.06704.1e Tep-areenan, 2003, Mechanisms of vasorelaxation to testosterone in the rat aorta, Eur. J. Pharmacol., 465, 125, 10.1016/S0014-2999(03)01453-5 Tan, 2018, Testosterone to estrogen conversion is not responsible for the vasodilating effects of testosterone ex vivo, Cell. Mol. Biol., 64, 111, 10.14715/cmb/2018.64.2.20 Ramirez-Rosas, 2011, Pharmacological evidence that Ca(2)+ channels and, to a lesser extent, K+ channels mediate the relaxation of testosterone in the canine basilar artery, Steroids, 76, 409, 10.1016/j.steroids.2010.12.012 Deenadayalu, 2001, Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel, Am. J. Physiol., 281, H1720 Montano, 2008, Relaxation of androgens on rat thoracic aorta: testosterone concentration dependent agonist/antagonist L-type Ca2+ channel activity, and 5beta-dihydrotestosterone restricted to L-type Ca2+ channel blockade, Endocrinology, 149, 2517, 10.1210/en.2007-1288 Isidoro, 2018, Vasoactive androgens: vasorelaxing effects and their potential regulation of blood pressure, Endocr. Res., 43, 166, 10.1080/07435800.2018.1448868 Perusquia, 2018, Antihypertensive responses of vasoactive androgens in an in vivo experimental model of preeclampsia, J. Steroid Biochem. Mol. Biol., 178, 65, 10.1016/j.jsbmb.2017.11.001 Perusquia, 2012, Regional differences in the vasorelaxing effects of testosterone and its 5-reduced metabolites in the canine vasculature, Vascul. Pharmacol., 56, 176, 10.1016/j.vph.2012.01.008 Murphy, 1999, Decreased [Ca2+]i during inhibition of coronary smooth muscle contraction by 17beta-estradiol, progesterone, and testosterone, J. Pharmacol. Exp. Ther., 291, 44 English, 2000, Aging reduces the responsiveness of coronary arteries from male Wistar rats to the vasodilatory action of testosterone, Clin. Sci., 99, 77, 10.1042/cs0990077 English, 2002, Testosterone acts as a coronary vasodilator by a calcium antagonistic action, J. Endocrinol. Invest., 25, 455, 10.1007/BF03344037 Perusquia, 1996, Role of endothelium in the vasodilating effect of progestins and androgens on the rat thoracic aorta, Gen. Pharmacol., 27, 181, 10.1016/0306-3623(95)00091-7 Honda, 1999, Different mechanisms for testosterone-induced relaxation of aorta between normotensive and spontaneously hypertensive rats, Hypertension, 34, 1232, 10.1161/01.HYP.34.6.1232 Ding, 2001, Testosterone-induced relaxation of rat aorta is androgen structure specific and involves K+ channel activation, J. Appl. Physiol., 91, 2742, 10.1152/jappl.2001.91.6.2742 Jones, 2002, Pulmonary vasodilatory action of testosterone: evidence of a calcium antagonistic action, J. Cardiovasc. Pharmacol., 39, 814, 10.1097/00005344-200206000-00006 Rowell, 2009, Testosterone acts as an efficacious vasodilator in isolated human pulmonary arteries and veins: evidence for a biphasic effect at physiological and supra-physiological concentrations, J. Endocrinol. Invest., 32, 718, 10.1007/BF03346526 Seyrek, 2007, Testosterone relaxes isolated human radial artery by potassium channel opening action, J. Pharmacol. Sci., 103, 309, 10.1254/jphs.FP0060883 Cairrao, 2008, Potassium channels are involved in testosterone-induced vasorelaxation of human umbilical artery, Naunyn Schmiedebergs Arch. Pharmacol., 376, 375, 10.1007/s00210-007-0213-3 Cairrao, 2010, PKG is involved in testosterone-induced vasorelaxation of human umbilical artery, Eur. J. Pharmacol., 640, 94, 10.1016/j.ejphar.2010.04.025 Han, 2008, Effect of testosterone on potassium channel opening in human corporal smooth muscle cells, J. Sex. Med., 5, 822, 10.1111/j.1743-6109.2007.00732.x Lu, 2012, The vasodilatory effect of testosterone on renal afferent arterioles, Gend. Med., 9, 103, 10.1016/j.genm.2012.02.003 Teoh, 2000, Differential effects of 17beta-estradiol and testosterone on the contractile responses of porcine coronary arteries, Br. J. Pharmacol., 129, 1301, 10.1038/sj.bjp.0703164 Gorczynska, 1995, Androgens rapidly increase the cytosolic calcium concentration in Sertoli cells, Endocrinology, 136, 2052, 10.1210/endo.136.5.7720654 Steinsapir, 1991, Effects of androgen on intracellular calcium of LNCaP cells, Biochem. Biophys. Res. Commun., 179, 90, 10.1016/0006-291X(91)91338-D Yu, 2012, Src kinase-mediates androgen receptor-dependent non-genomic activation of signaling cascade leading to endothelial nitric oxide synthase, Biochem. Biophys. Res. Commun., 424, 538, 10.1016/j.bbrc.2012.06.151 Thomas, 2018, ZIP9, a novel membrane androgen receptor and zinc transporter protein, Gen. Comp. Endocrinol., 257, 130, 10.1016/j.ygcen.2017.04.016 Wang, 2014, G protein-coupled receptors: extranuclear mediators for the non-genomic actions of steroids, Int. J. Mol. Sci., 15, 15412, 10.3390/ijms150915412 Pi, 2010, GPRC6A mediates the non-genomic effects of steroids, J. Biol. Chem., 285, 39953, 10.1074/jbc.M110.158063 Pi, 2017, GPRC6A: Jack of all metabolism (or master of none), Mol. Metab., 6, 185, 10.1016/j.molmet.2016.12.006 Pi, 2015, Structural and functional evidence for testosterone activation of GPRC6A in peripheral tissues, Mol. Endocrinol., 29, 1759, 10.1210/me.2015-1161 Ye, 2019, Human GPRC6A mediates testosterone-induced mitogen-activated protein kinases and mTORC1 signaling in prostate Cancer cells, Mol. Pharmacol., 95, 563, 10.1124/mol.118.115014 Kalyvianaki, 2017, Antagonizing effects of membrane-acting androgens on the eicosanoid receptor OXER1 in prostate cancer, Sci. Rep., 7, 10.1038/srep44418 Thomas, 2008, Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions, Front. Neuroendocrinol., 29, 292, 10.1016/j.yfrne.2008.01.001 Asuthkar, 2015, The TRPM8 protein is a testosterone receptor: II. Functional evidence for an ionotropic effect of testosterone on TRPM8, J. Biol. Chem., 290, 2670, 10.1074/jbc.M114.610873 Asuthkar, 2015, The TRPM8 protein is a testosterone receptor: I. Biochemical evidence for direct TRPM8-testosterone interactions, J. Biol. Chem., 290, 2659, 10.1074/jbc.M114.610824 Yee, 2015, Roles of TRPM8 ion channels in Cancer: proliferation, survival, and invasion, Cancers, 7, 2134, 10.3390/cancers7040882 Thomas, 2014, Identification and characterization of membrane androgen receptors in the ZIP9 zinc transporter subfamily: II. Role of human ZIP9 in testosterone-induced prostate and breast cancer cell apoptosis, Endocrinology, 155, 4250, 10.1210/en.2014-1201 Berg, 2014, Identification and characterization of membrane androgen receptors in the ZIP9 zinc transporter subfamily: I. Discovery in female Atlantic croaker and evidence ZIP9 mediates testosterone-induced apoptosis of ovarian follicle cells, Endocrinology, 155, 4237, 10.1210/en.2014-1198 Hotta, 2019, Testosterone deficiency and endothelial dysfunction: nitric oxide, asymmetric dimethylarginine, and endothelial progenitor cells, Sex. Med. Rev., 10.1016/j.sxmr.2019.02.005 Higashi, 2017, Lower urinary tract symptoms/benign prostatic hypertrophy and vascular function: role of the nitric oxide-phosphodiesterase type 5-cyclic guanosine 3′,5′-monophosphate pathway, Int. J. Urol., 24, 412, 10.1111/iju.13336 Vanhoutte, 1988, The endothelium - modulation of vascular smooth-muscle tone, N. Engl. J. Med., 319, 512, 10.1056/NEJM198808253190809 Vanhoutte, 1988, Endothelium and the control of vascular smooth muscle, 119 Villar, 2006, Novel aspects of endothelium-dependent regulation of vascular tone, Kidney Int., 70, 840, 10.1038/sj.ki.5001680 Smith, 2000, Cyclooxygenases: structural, cellular, and molecular biology, Annu. Rev. Biochem., 69, 145, 10.1146/annurev.biochem.69.1.145 Majed, 2012, Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn, Pharmacol. Rev., 64, 540, 10.1124/pr.111.004770 Moncada, 1991, Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol. Rev., 43, 109 Crews, 1999, Antagonistic effects of 17 b-estradiol, progesterone, and testosterone on Ca2+ entry mechanisms of coronary vasoconstriction, Arterioscler. Thromb. Vasc. Biol., 19, 1034, 10.1161/01.ATV.19.4.1034 Crews, 1999, Gender differences in Ca2+ entry mechanisms of vasoconstriction in Wistar-Kyoto and spontaneously hypertensive rats, Hypertension, 34, 931, 10.1161/01.HYP.34.4.931 Honda, 2001, Spatiotemporal dynamics of guanosine 3′,5′-cyclic monophosphate revealed by a genetically encoded, fluorescent indicator, Proc. Natl. Acad. Sci. U. S. A., 98, 2437, 10.1073/pnas.051631298 Jones, 2004, Testosterone-induced coronary vasodilatation occurs via a non-genomic mechanism: evidence of a direct calcium antagonism action, Clin. Sci., 107, 149, 10.1042/CS20030386 Goetz, 1999, Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase, Proc. Natl. Acad. Sci. U. S. A., 96, 2788, 10.1073/pnas.96.6.2788 Hishikawa, 1995, Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells, FEBS Lett., 360, 291, 10.1016/0014-5793(95)00124-R Costarella, 1996, Testosterone causes direct relaxation of rat thoracic aorta, J. Pharmacol. Exp. Ther., 277, 34 Unemoto, 2007, Role of BK channels in testosterone-induced relaxation of the aorta in spontaneously hypertensive rats, Biol. Pharm. Bull., 30, 1477, 10.1248/bpb.30.1477 Marrachelli, 2010, Mechanisms involved in the relaxant action of testosterone in the renal artery from male normoglycemic and diabetic rabbits, Pharmacol. Res., 61, 149, 10.1016/j.phrs.2009.09.002 Yildirim, 2011, The effects of testosterone on isolated sheep coronary artery, Anadolu Kardiyol. Derg., 11, 343 Yu, 2010, Androgen receptor-dependent activation of endothelial nitric oxide synthase in vascular endothelial cells: role of phosphatidylinositol 3-Kinase/Akt pathway, Endocrinology, 151, 1822, 10.1210/en.2009-1048 Goglia, 2010, Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo, Mol. Hum. Reprod., 16, 761, 10.1093/molehr/gaq049 Campelo, 2012, Cellular actions of testosterone in vascular cells: mechanism independent of aromatization to estradiol, Steroids, 77, 1033, 10.1016/j.steroids.2012.05.008 Ma, 2009, [Testosterone at physiological level inhibits PGF2alpha-induced increase in intracellular Ca2+ in cultured vascular smooth muscle cells], Zhonghua Nan Ke Xue, 15, 326 Ruamyod, 2017, Testosterone rapidly increases Ca(2+)-activated K(+) currents causing hyperpolarization in human coronary artery endothelial cells, J. Steroid Biochem. Mol. Biol., 168, 118, 10.1016/j.jsbmb.2017.02.014 Zhao, 2018, Effect of low androgen levels on IKca and SKca3 channels in rat penile corpus cavernosum, Andrologia, 50, 10.1111/and.13075 Riedel, 2019, Estrogen determines sex differences in adrenergic vessel tone by regulation of endothelial beta-adrenoceptor expression, Am. J. Physiol. Heart Circul. Physiol., 317, H243, 10.1152/ajpheart.00456.2018 Cui, 2019, Testosterone preserves endothelial function through regulation of S1P1/Akt/FOXO3a signalling pathway in the rat corpus cavernosum, Andrologia, 51, 10.1111/and.13173 Aversa, 2019, Androgen deficiency and phosphodiesterase type 5 expression changes in aging male: therapeutic implications, Front. Endocrinol., 10, 225, 10.3389/fendo.2019.00225 Usselman, 2019, Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor, J. Physiol. (Lond.), 597, 2853, 10.1113/JP277756 Jackson, 2018, KV channels and the regulation of vascular smooth muscle tone, Microcirculation, 25, 10.1111/micc.12421 Jackson, 2000, Ion channels and vascular tone, Hypertension, 35, 173, 10.1161/01.HYP.35.1.173 Lorigo, 2018, How is the human umbilical artery regulated?, J. Obstet. Gynaecol. Res., 10.1111/jog.13667 Catterall, 2011, Voltage-gated calcium channels, Cold Spring Harb. Perspect. Biol., 3, 10.1101/cshperspect.a003947 Ghosh, 2017, Calcium channels in vascular smooth muscle, Adv. Pharmacol., 78, 49, 10.1016/bs.apha.2016.08.002 Malkin, 2006, Effect of testosterone on ex vivo vascular reactivity in man, Clin. Sci., 111, 265, 10.1042/CS20050354 Perusquia, 2007, The modulatory role of androgens and progestins in the induction of vasorelaxation in human umbilical artery, Life Sci., 81, 993, 10.1016/j.lfs.2007.07.024 Yildiz, 2005, The relationship between risk factors and testosterone-induced relaxations in human internal mammary artery, J. Cardiovasc. Pharmacol., 45, 4, 10.1097/00005344-200501000-00002 Won, 2003, Testosterone causes simultaneous decrease of [Ca2+]I and tension in rabbit coronary arteries: by opening voltage dependent potassium channels, Yonsei Med. J., 44, 1027, 10.3349/ymj.2003.44.6.1027 Ohya, 2019, Castration induces down-regulation of A-Type K(+) channel in rat vas deferens smooth muscle, Int. J. Mol. Sci., 20, 10.3390/ijms20174073 Deenadayalu, 2012, Testosterone-induced relaxation of coronary arteries: activation of BKCa channels via the cGMP-dependent protein kinase, Am. J. Physiol. Heart Circul. Physiol., 302, H115, 10.1152/ajpheart.00046.2011 Hristov, 2016, Testosterone decreases urinary bladder smooth muscle excitability via novel signaling mechanism involving direct activation of the BK channels, Am. J. Physiol. Renal Physiol., 311, F1253, 10.1152/ajprenal.00238.2016 Feiteiro, 2014, Testosterone and atrial natriuretic Peptide share the same pathway to induce vasorelaxation of human umbilical artery, J. Cardiovasc. Pharmacol., 63, 461, 10.1097/FJC.0000000000000060 Perusquia, 1999, Possible role of Ca2+ channels in the vasodilating effect of 5-beta-dihydrotestosterone in rat aorta, Eur. J. Pharmacol., 371, 169, 10.1016/S0014-2999(99)00161-2 Perusquia, 2015, Testosterone-induced relaxation involves L-type and store-operated Ca2+ channels blockade, and PGE 2 in guinea pig airway smooth muscle, Pflugers Arch., 467, 767, 10.1007/s00424-014-1534-y Flores-Soto, 2017, Sex steroids effects on guinea pig airway smooth muscle tone and intracellular Ca(2+) basal levels, Mol. Cell. Endocrinol., 439, 444, 10.1016/j.mce.2016.10.004 Montano, 2018, Testosterone induces hyporesponsiveness by interfering with IP3 receptors in guinea pig airway smooth muscle, Mol. Cell. Endocrinol., 473, 17, 10.1016/j.mce.2017.12.010 Crews, 1999, Gender-specific inhibition of Ca2+ entry mechanisms of arterial vasoconstriction by sex hormones, Clin. Exp. Pharmacol. Physiol., 26, 707, 10.1046/j.1440-1681.1999.03110.x Hu, 2016, Investigation of testosterone-mediated non-transcriptional inhibition of Ca(2+) in vascular smooth muscle cells, Biomed. Rep., 4, 197, 10.3892/br.2015.557 Navarro-Dorado, 2008, Mechanisms involved in testosterone-induced vasodilatation in pig prostatic small arteries, Life Sci., 83, 569, 10.1016/j.lfs.2008.08.009 Scragg, 2004, Testosterone is a potent inhibitor of L-type Ca2+ channels, Biochem. Biophys. Res. Commun., 318, 503, 10.1016/j.bbrc.2004.04.054 Hall, 2006, Selective inhibition of L-type Ca2+ channels in A7r5 cells by physiological levels of testosterone, Endocrinology, 147, 2675, 10.1210/en.2005-1243 Scragg, 2007, Molecular requirements for L-type Ca2+ channel blockade by testosterone, Cell Calcium, 42, 11, 10.1016/j.ceca.2006.11.003 Alvarez, 2010, Testosterone and cholesterol vasodilation of rat aorta involves L-type calcium channel inhibition, Adv. Pharmacol. Sci., 2010, 1, 10.1155/2010/534184 Perusquia, 2017, Antihypertensive effects of androgens in conscious, spontaneously hypertensive rats, J. Steroid Biochem. Mol. Biol., 167, 106, 10.1016/j.jsbmb.2016.11.016 Mandegar, 2002, Role of K+ channels in pulmonary hypertension, Vascul. Pharmacol., 38, 25, 10.1016/S1537-1891(02)00123-4 Bonnet, 2007, Potassium channel diversity in the pulmonary arteries and pulmonary veins: implications for regulation of the pulmonary vasculature in health and during pulmonary hypertension, Pharmacol. Ther., 115, 56, 10.1016/j.pharmthera.2007.03.014 Feiteiro, 2016, Cyclic guanosine monophosphate compartmentation in human vascular smooth muscle cells, Cell. Signal., 28, 109, 10.1016/j.cellsig.2015.12.004 Martin de Llano, 2007, Procedure to consistently obtain endothelial and smooth muscle cell cultures from umbilical cord vessels, Transl. Res., 149, 1, 10.1016/j.trsl.2006.07.010 Harada, 2018, Role of androgens in energy metabolism affecting on body composition, metabolic syndrome, type 2 diabetes, cardiovascular disease, and longevity: lessons from a meta-analysis and rodent studies, Biosci. Biotechnol. Biochem., 82, 1667, 10.1080/09168451.2018.1490172 Alexandersen, 1996, The relationship of natural androgens to coronary heart disease in males: a review, Atherosclerosis, 125, 1, 10.1016/0021-9150(96)05864-9 English, 2000, Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms, Eur. Heart J., 21, 890, 10.1053/euhj.1999.1873 English, 1997, Testosterone and coronary heart disease: is there a link?, QJM, 90, 787, 10.1093/qjmed/90.12.787 Kelly, 2013, Testosterone: a vascular hormone in health and disease, J. Endocrinol., 217, R47, 10.1530/JOE-12-0582 Pantalone, 2019, Testosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality, Basic Clin. Androl., 29, 5, 10.1186/s12610-019-0085-7 Corona, 2011, Testosterone and metabolic syndrome: a meta-analysis study, J. Sex. Med., 8, 272, 10.1111/j.1743-6109.2010.01991.x Corona, 2013, Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes, Best Pract. Res. Clin. Endocrinol. Metab., 27, 557, 10.1016/j.beem.2013.05.002 Brand, 2011, Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies, Int. J. Epidemiol., 40, 189, 10.1093/ije/dyq158 Brand, 2014, Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies, PLoS One, 9, 10.1371/journal.pone.0100409 Corona, 2011, Type 2 diabetes mellitus and testosterone: a meta-analysis study, Int. J. Androl., 34, 528, 10.1111/j.1365-2605.2010.01117.x Ding, 2006, Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis, JAMA, 295, 1288, 10.1001/jama.295.11.1288 Cai, 2014, Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials, Asian J. Androl., 16, 146, 10.4103/1008-682X.122346 Kovac, 2014, Testosterone supplementation therapy in the treatment of patients with metabolic syndrome, Postgrad. Med., 126, 149, 10.3810/pgm.2014.11.2843 Traish, 2009, The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction, J. Androl., 30, 10, 10.2164/jandrol.108.005215 Bianchi, 2018, Testosterone a key factor in gender related metabolic syndrome, Obes. Rev., 19, 557, 10.1111/obr.12633 Kelly, 2015, Testosterone and obesity, Obes. Rev., 16, 581, 10.1111/obr.12282 Chen, 2006, Relative androgen deficiency in relation to obesity and metabolic status in older men, Diabetes Obes. Metab., 8, 429, 10.1111/j.1463-1326.2005.00532.x Traish, 2015, The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease, Rev. Endocr. Metab. Disord., 16, 249, 10.1007/s11154-015-9323-2 van den Beld, 2003, Endogenous hormones and carotid atherosclerosis in elderly men, Am. J. Epidemiol., 157, 25, 10.1093/aje/kwf160 Fukui, 2003, Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes, Diabetes Care, 26, 1869, 10.2337/diacare.26.6.1869 Svartberg, 2006, Low testosterone levels are associated with carotid atherosclerosis in men, J. Intern. Med., 259, 576, 10.1111/j.1365-2796.2006.01637.x De Pergola, 2003, Free testosterone plasma levels are negatively associated with the intima-media thickness of the common carotid artery in overweight and obese glucose-tolerant young adult men, Int. J. Obes. Relat. Metab. Disord., 27, 803, 10.1038/sj.ijo.0802292 Muller, 2004, Endogenous sex hormones and progression of carotid atherosclerosis in elderly men, Circulation, 109, 2074, 10.1161/01.CIR.0000125854.51637.06 Makinen, 2005, Increased carotid atherosclerosis in andropausal middle-aged men, J. Am. Coll. Cardiol., 45, 1603, 10.1016/j.jacc.2005.01.052 Snyder, 2018, Lessons from the testosterone trials, Endocr. Rev., 39, 369, 10.1210/er.2017-00234 Helkin, 2016, Dyslipidemia part 1--Review of lipid metabolism and vascular cell physiology, Vasc. Endovascular Surg., 50, 107, 10.1177/1538574416628654 Traish, 2009, Androgen deficiency and atherosclerosis: the lipid link, Vascul. Pharmacol., 51, 303, 10.1016/j.vph.2009.09.003 Mohler, 2018, The effect of testosterone on cardiovascular biomarkers in the testosterone trials, J. Clin. Endocrinol. Metab., 103, 681, 10.1210/jc.2017-02243 Zitzmann, 2007, Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men, J. Clin. Endocrinol. Metab., 92, 3844, 10.1210/jc.2007-0620 Traish, 2011, Testosterone deficiency, Am. J. Med., 124, 578, 10.1016/j.amjmed.2010.12.027 Keya, 2019, Relationship between free testosterone and preeclampsia, Mymensingh Med. J., 28, 574 Hackett, 2019, Metabolic effects of testosterone therapy in men with type 2 diabetes and metabolic syndrome, Sex. Med. Rev., 7, 476, 10.1016/j.sxmr.2018.12.004 Chistiakov, 2018, Role of androgens in cardiovascular pathology, Vasc. Health Risk Manag., 14, 283, 10.2147/VHRM.S173259